In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004)

Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically

Mary Jane Ferraro · 2000 · 16.9K citations

Life Sciences, Microbiology, Bacteriology +10

In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9- <i>t</i> -Butylglycylamido Derivative of Minocycline (GAR-936)

Peter J. Petersen, N V Jacobus, Jason Weiss et al. · Antimicrobial Agents and Chemotherapy · 1999 · 411 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of <i>Escherichia coli</i> from Female Outpatients in the United States

James A. Karlowsky, Laurie J. Kelly, Clyde Thornsberry et al. · Antimicrobial Agents and Chemotherapy · 2002 · 369 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Efflux-Mediated Resistance to Tigecycline (GAR-936) in <i>Pseudomonas aeruginosa</i> PAO1

Charles R. Dean, M Visalli, Steven J. Projan et al. · Antimicrobial Agents and Chemotherapy · 2003 · 284 citations · Full text

Life Sciences, Microbiology, Antimicrobial Resistance +16

Comparison of the In Vitro Activity of the Glycylcycline Tigecycline (Formerly GAR-936) with Those of Tetracycline, Minocycline, and Doxycycline against Isolates of Nontuberculous Mycobacteria

Richard J. Wallace, Barbara A. Brown‐Elliott, Christopher J. Crist et al. · Antimicrobial Agents and Chemotherapy · 2002 · 227 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14